Press Release FeedGet the RSS feed
Menu

Business Wire

UNIFI®, Makers of REPREVE®, Reports Fourth Quarter Revenue Growth, Higher Margins, and Cash Generation

Business Wire

Fourth quarter revenue growth, disciplined cost execution, and stronger cash generation highlight continued progress in operational turnaround

GREENSBORO, N.C., August 19, 2026--Unifi, Inc. (NYSE: UFI), the makers of REPREVE® and one of the world's leading innovators in recycled and synthetic yarns, today released operating results for the fourth fiscal quarter and fiscal year ended June 28, 2026.

Fourth Quarter Fiscal 2026 Highlights

  • Net sales were $144.2 million, an increase of 4.1% from the fourth quarter of fiscal 2025.

  • Revenues from REPREVE Fiber products were $40.2 million and represented 28% of net sales.

  • Gross profit was $14.3 million and gross margin was 9.9%, compared to gross loss of $1.1 million and gross margin of (0.8)% for the fourth quarter of fiscal 2025.

  • SG&A expenses were $11.8 million, a decrease of 1.0% from the fourth quarter of fiscal 2025, primarily driven by cost reduction efforts.

  • Net loss was $1.2 million, or $0.06 per share, compared to net income of $15.5 million, or $0.82 per share, for the fourth quarter of fiscal 2025, which included a $35.8 million gain on the sale of a manufacturing facility, partially offset by $10.6 million in transition costs.

  • Adjusted EBITDA* was $8.2 million, compared to $(4.1) million for the fourth quarter of fiscal 2025.

  • Cash provided by operating activities was $2.1 million during the fourth quarter of fiscal 2026 and $26.5 million during fiscal 2026.

  • Debt principal was $92.4 million and Net Debt* was $67.4 million at June 28, 2026.

  • Following the fourth fiscal quarter, the Company entered into an agreement to sell certain non-strategic real estate assets within the Americas Segment for $60.0 million of gross proceeds. Upon closing, the transaction will significantly enhance financial flexibility, support debt reduction, and further strengthen the balance sheet, with no expected impact on customer service or daily operations.

Eddie Ingle, Chief Executive Officer of Unifi, Inc., stated, "We closed fiscal 2026 with clear momentum, highlighted by meaningful improvement in profitability and cash generation. These results reflect disciplined execution of our cost reduction, operational optimization, and portfolio management initiatives, each of which have driven lower our revenue break-even point. As we enter fiscal 2027, UNIFI is operating from a healthier financial position, with a more focused cost structure and a balance sheet that we expect to further strengthen through the planned sale of non-strategic real estate assets."

  1. HealthcareAV Laboratories Joins Regenivus (Mitrone Healthcare Ltd.) at Dublin’s Aesthetic & Regenerative Medicine ConferenceDUBLIN, October 18, 2026--AV Laboratories, a clinical skin longevity brand bridging advanced formulation science and skincare innovation, is pleased to announce its participation in The Aesthetic & Regenerative Medicine Conference, taking place on 18–19 October 2026 at Croke Park, Dublin. The brand wil
  2. FUJIFILM Integrated Inkjet SolutionsFujifilm Introduces FUJIFILM HX1024 Printbar SystemNew printbar brings full-color customizable on-demand digital printing to building products LEBANON, N.H., October 18, 2026--FUJIFILM Integrated Inkjet Solutions today announced the introduction of the FUJIFILM HX1024 Printbar System, designed to support customized printing using the company's advanced
  3. EnergyWorld’s First Commercial Ship-to-Ship Green Ammonia Bunkering Completed in Zhoushan, Zhejiang, ChinaZHOUSHAN, China, October 18, 2026--On October 13, 2026, the world's first commercial ship-to-ship bunkering of green ammonia fuel was completed at an anchorage in Zhoushan Port, Zhejiang Province, China. A total of 1,000 tonnes of green ammonia from the HyFlow-1 Songyuan Hydrogen Energy Industrial Park
  4. SaaSThe Prostate Cancer FoundationProstate Cancer Foundation Expands Radiopharmaceutical Think Tank as Field Enters Pivotal Growth Phase– PCF Think Tank aims to increase adoption of radiopharmaceuticals as major oncology therapeutic platform in prostate cancer treatment and to other tumor types – – New members Orano Med, Telix and Siemens Healthineers join PCF and industry leaders at kickoff meeting at 2026 EANM Annual Congress to address key challenges i
  5. FinanceAlign Technology, Inc.Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent CourtCompanies: Align TechnologySAN JOSE, Calif. & TEMPE, Ariz., October 17, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court ("UPC") finding that aligner syst
  6. AISyncra and Neumetry Partner to Build AI-Powered Readiness Platform for Teenage Athletes and Their CoachesSmart ring data meets FDA-cleared physiological AI to help coaches see which athletes are ready to compete, and which need rest LAS VEGAS & SAN JOSE, Calif., October 17, 2026--Syncra Labs Inc., maker of the Syncra smart ring, and Neumetry Medical, Inc., developer of an FDA-cleared predictive health pla